º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Enterprise

'Herculean effort' praised by Scapa Group as it returned to profit ahead of £400m deal

Scapa Group had been listed on AIM

Greater Manchester-based Scapa Group specialises in woundcare

A Greater Manchester-based healthcare and industrial business, which was recently acquired by a global engineering and manufacturing firm in a deal worth over £400m, returned to making a pre-tax profit during its latest financial year.

Scapa Group has reported a profit of £5.5m for the 12 months to March 31, 2021, after posting a loss of £51m in the prior year.

The group's revenue dipped during the period from £320.6m to £272.5m.

The accounts are the first since it was snapped up by AMS Holdco 2, a subsidiary of US-based Schweitzer-Mauduit International Inc (SWM), in April this year.

Ashton-under-Lyne-based Scapa Group, which had been listed on the London Stock Exchange's AIM, specialises in wound care, with sales operations around North America, Europe and Asia.

SWM is a global performance materials company, engineering films, nets and papers - serving markets from medical to tobacco to home décor.

A statement signed off by the Scapa board said: "The execution of our strategy is reliant on our people and our entrepreneurial culture.